AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma

Oncogene

Volumn 30, Issue 10, 2011, Pages 1229-1240

  Xu, M Z ^a,b   Chan, S W ^c   Liu, A M ^b,d   Wong, K F ^b,d   Fan, S T ^b   Chen, J ^a   Poon, R T ^b   Zender, L ^e   Lowe, S W ^f   Hong, W ^c   Luk, J M ^a,b,d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^e HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

AXL receptor kinase; cancer signaling; HCC; hepatocellular carcinoma; Hippo pathway; YAP1 oncogene

Indexed keywords

ALPHA FETOPROTEIN; AXL RECEPTOR KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL VIABILITY; HUMAN; HUMAN CELL; LIVER CELL; LIVER CELL CARCINOMA; LOSS OF FUNCTION MUTATION; MALE; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TUMOR XENOGRAFT; YES ASSOCIATED PROTEIN 1 ONCOGENE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOBLOTTING; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS;

EID: 79952532529     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.504     Document Type: Article

References (46)

1. Bandura JL, Edgar BA. (2008). Yorkie and Scalloped: partners in growth activation. Dev Cell 14: 315-316.
2. Berclaz G, Altermatt HJ, Rohrbach V, Kieffer I, Dreher E, Andres AC. (2001). Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast. Ann Oncol 12: 819-824. (Pubitemid 32655092)
3. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendrix M et al. (2000). Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406: 536-540. (Pubitemid 30625740)
4. Bueno L, De Alwis DP, Pitou C, Yingling J, Lahn M, Glatt S et al. (2008). Semi-mechanistic modelling of the tumour growth inhibitory effects of LY2157299, a new type I receptor TGF-beta kinase antagonist, in mice. Eur J Cancer 44: 142-150. (Pubitemid 350256941)
5. Buttitta LA, Edgar BA. (2007). How size is controlled: from Hippos to Yorkies. Nat Cell Biol 9: 1225-1227. (Pubitemid 350042352)
6. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R et al. (2007). YAP1 increases organ size and expands undiffer-entiated progenitor cells. Curr Biol 17: 2054-2060. (Pubitemid 350180465)
7. Cao X, Pfaff SL, Gage FH. (2008). YAP regulates neural progenitor cell number via the TEA domain transcription factor. Genes Dev 22: 3320-3334.
8. Chan SW, Lim CJ, Loo LS, Chong YF, Huang C, Hong W. (2009). TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation. J Biol Chem 284: 14347-14358.
9. Craven RJ, Xu LH, Weiner TM, Fridell YW, Dent GA, Srivastava S et al. (1995). Receptor tyrosine kinases expressed in metastatic colon cancer. Int J Cancer 60: 791-797.
10. Demarchi F, Verardo R, Varnum B, Brancolini C, Schneider C. (2001). Gas6 anti-apoptotic signaling requires NF-kappa B activation. J Biol Chem 276: 31738-31744.
11. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA et al. (2007). Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120-1133. (Pubitemid 47410268)
12. Edgar BA. (2006). From cell structure to transcription: Hippo forges a new path. Cell 124: 267-273. (Pubitemid 43121976)
13. Goruppi S, Ruaro E, Schneider C. (1996). Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene 12: 471-480. (Pubitemid 26059640)
14. Hafizi S, Dahlback B. (2006). Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases. Cytokine Growth Factor Rev 17: 295-304. (Pubitemid 44038616)
15. Hao Y, Chun A, Cheung K, Rashidi B, Yang X. (2008). Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 283: 5496-5509.
16. Hasanbasic I, Cuerquis J, Varnum B, Blostein MD. (2004). Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells. Am J Physiol Heart Circ Physiol 287: H1207-H1213. (Pubitemid 39096668)
17. Huang J, Wu S, Barrera J, Matthews K, Pan D. (2005). The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell 122: 421-434. (Pubitemid 41127143)
18. Lay JD, Hong CC, Huang JS, Yang YY, Pao CY, Liu CH et al. (2007). Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL. Cancer Res 67: 3878-3887.
19. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH et al. (2008). TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 28: 2426-2436. (Pubitemid 351429986)
20. Liu AM, Xu MZ, Chen J, Poon RT, Luk JM. (2010). Targeting YAP and Hippo signaling pathway in liver cancer. Expert Opin Ther Targets 14: 855-868.
21. Liu LX, Lee NP, Chan VW, Xue W, Zender L, Zhang C et al. (2009). Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology 50: 1453-1463.
22. Luk JM, Wang PP, Lee CK, Wang JH, Fan ST. (2005). Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. J Immunol Methods 305: 39-47. (Pubitemid 41416720)
23. Oh H, Irvine KD. (2010). Yorkie: the final destination of Hippo signaling. Trends Cell Biol 20: 410-417.
24. Overholtzer M, Zhang J, Smolen GA, Muir B, Li W, Sgroi DC et al. (2006). Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci USA 103: 12405-12410. (Pubitemid 44267272)
25. Pan D. (2007). Hippo signaling in organ size control. Genes Dev 21: 886-897. (Pubitemid 46625638)
26. Peeper D, Berns A. (2006). Cross-species oncogenomics in cancer gene identification. Cell 125: 1230-1233. (Pubitemid 43929103)
27. Sainaghi PP, Castello L, Bergamasco L, Galletti M, Bellosta P, Avanzi GC. (2005). Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor. J Cell Physiol 204: 36-44. (Pubitemid 40776804)
28. Sawabu T, Seno H, Kawashima T, Fukuda A, Uenoyama Y, Kawada M et al. (2007). Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Mol Carcinog 46: 155-164.
29. Shieh YS, Lai CY, Kao YR, Shiah SG, Chu YW, Lee HS et al. (2005). Expression of axl in lung adenocarcinoma and correlation with tumor progression. Neoplasia 7: 1058-1064.
30. Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D et al. (2008). Expression of Yes-associated protein in common solid tumors. Hum Pathol 39: 1582-1589.
31. Tai KY, Shieh YS, Lee CS, Shiah SG, Wu CW. (2008). Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1. Oncogene 27: 4044-4055.
32. Thompson BJ, Cohen SM. (2006). The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell 126: 767-774. (Pubitemid 44233623)
33. Tsou AP, Wu KM, Tsen TY, Chi CW, Chiu JH, Lui WY et al. (1998). Parallel hybridization analysis of multiple protein kinase genes: identification of gene expression patterns characteristic of human hepatocellular carcinoma. Genomics 50: 331-340.
34. Wong BW, Luk JM, Ng IO, Hu MY, Liu KD, Fan ST. (2003). Identification of liver-intestine cadherin in hepatocellular carcino-ma-a potential disease marker. Biochem Biophys Res Commun 311: 618-624. (Pubitemid 37377699)
35. Wu S, Liu Y, Zheng Y, Dong J, Pan D. (2008). The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell 14: 388-398.
36. Xu MZ, Yao TJ, Lee NP, Ng IO, Chan YT, Zender L et al. (2009). Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115: 4576-4585.
37. Yin F, Pan D. (2007). Fat flies expanded the hippo pathway: a matter of size control. Sci STKE 2007: pe12.
38. Zender L, Lowe SW. (2008). Integrative oncogenomic approaches for accelerated cancer-gene discovery. Curr Opin Oncol 20: 72-76. (Pubitemid 350190984)
39. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J et al. (2006). Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125: 1253-1267. (Pubitemid 43929093)
40. Zender L, Xue W, Zuber J, Semighini CP, Krasnitz A, Ma B et al. (2008). An oncogenomics- based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135: 852-864.
41. Zeng Q, Hong W. (2008). The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell 13: 188-192. (Pubitemid 351318373)
42. Zhang YX, Knyazev PG, Cheburkin YV, Sharma K, Knyazev YP, Orfi L et al. (2008). AXL is a potential target for therapeutic intervention in breast cancer progression. Cancer Res 68: 1905-1915. (Pubitemid 351416577)
43. Zhao B, Lei QY, Guan KL. (2008a). The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol 20: 638-646.
44. Zhao B, Li L, Tumaneng K, Wang CY, Guan KL. (2010). A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24: 72-85.
45. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J et al. (2007). Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747-2761. (Pubitemid 350070721)
46. Zhao B, Ye X, Yu J, Li L, Li W, Li S et al. (2008b). TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962-1971. (Pubitemid 352008643)